SK280939B6 - Spôsob syntézy (4r-cis)-1,1-dimetyletyl-6-kyanometyl-2,2- -dimetyl-1,3-dioxán-4-acetátu a medziprodukty tohto spôsobu - Google Patents

Spôsob syntézy (4r-cis)-1,1-dimetyletyl-6-kyanometyl-2,2- -dimetyl-1,3-dioxán-4-acetátu a medziprodukty tohto spôsobu Download PDF

Info

Publication number
SK280939B6
SK280939B6 SK502-98A SK50298A SK280939B6 SK 280939 B6 SK280939 B6 SK 280939B6 SK 50298 A SK50298 A SK 50298A SK 280939 B6 SK280939 B6 SK 280939B6
Authority
SK
Slovakia
Prior art keywords
dimethyl
dioxane
acetate
cis
dimethylethyl
Prior art date
Application number
SK502-98A
Other languages
English (en)
Slovak (sk)
Inventor
Alan Millar
Donald Eugene Butler
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of SK280939B6 publication Critical patent/SK280939B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
SK502-98A 1990-10-17 1991-09-11 Spôsob syntézy (4r-cis)-1,1-dimetyletyl-6-kyanometyl-2,2- -dimetyl-1,3-dioxán-4-acetátu a medziprodukty tohto spôsobu SK280939B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/599,521 US5103024A (en) 1990-10-17 1990-10-17 Process for the synthesis of (4r-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
PCT/US1991/006697 WO1992006968A1 (en) 1990-10-17 1991-09-11 Process for the synthesis of (4r-cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate

Publications (1)

Publication Number Publication Date
SK280939B6 true SK280939B6 (sk) 2000-09-12

Family

ID=24399962

Family Applications (5)

Application Number Title Priority Date Filing Date
SK502-98A SK280939B6 (sk) 1990-10-17 1991-09-11 Spôsob syntézy (4r-cis)-1,1-dimetyletyl-6-kyanometyl-2,2- -dimetyl-1,3-dioxán-4-acetátu a medziprodukty tohto spôsobu
SK505-98A SK280942B6 (sk) 1990-10-17 1991-09-11 (4r-cis)-1,1-dimetyletyl-6-jódmetyl-2,2-dimetyl-1,3-dioxán-4- -acetát, spôsob jeho syntézy a medziprodukty na túto syntézu
SK504-98A SK280941B6 (sk) 1990-10-17 1991-09-11 (4r-cis)-1,1-dimetyletyl-6-arylsulfonyloxymetyl-2,2-dimetyl- -1,3-dioxán-4-acetáty a spôsob ich syntézy
SK503-98A SK280940B6 (sk) 1990-10-17 1991-09-11 Spôsob syntézy (4r-cis)-1,1-dimetyletyl-6-kyanometyl-2,2- -dimetyl-1,3-dioxán-4-acetátu a medziprodukty tohto spôsobu
SK339-93A SK280938B6 (sk) 1990-10-17 1991-09-11 Spôsob syntézy (4r-cis)-1,1-dimetyletyl-6-kyanometyl-2,2- -dimetyl-1,3-dioxán-4-acetátu a medziprodukty tohto spôsobu

Family Applications After (4)

Application Number Title Priority Date Filing Date
SK505-98A SK280942B6 (sk) 1990-10-17 1991-09-11 (4r-cis)-1,1-dimetyletyl-6-jódmetyl-2,2-dimetyl-1,3-dioxán-4- -acetát, spôsob jeho syntézy a medziprodukty na túto syntézu
SK504-98A SK280941B6 (sk) 1990-10-17 1991-09-11 (4r-cis)-1,1-dimetyletyl-6-arylsulfonyloxymetyl-2,2-dimetyl- -1,3-dioxán-4-acetáty a spôsob ich syntézy
SK503-98A SK280940B6 (sk) 1990-10-17 1991-09-11 Spôsob syntézy (4r-cis)-1,1-dimetyletyl-6-kyanometyl-2,2- -dimetyl-1,3-dioxán-4-acetátu a medziprodukty tohto spôsobu
SK339-93A SK280938B6 (sk) 1990-10-17 1991-09-11 Spôsob syntézy (4r-cis)-1,1-dimetyletyl-6-kyanometyl-2,2- -dimetyl-1,3-dioxán-4-acetátu a medziprodukty tohto spôsobu

Country Status (20)

Country Link
US (1) US5103024A (es)
EP (1) EP0553213B1 (es)
JP (1) JP3105923B2 (es)
KR (1) KR0166385B1 (es)
AT (1) ATE118772T1 (es)
AU (1) AU646311B2 (es)
CA (1) CA2092997C (es)
CZ (5) CZ283003B6 (es)
DE (1) DE69107622T2 (es)
DK (1) DK0553213T3 (es)
ES (1) ES2070519T3 (es)
FI (1) FI108539B (es)
HK (1) HK1005026A1 (es)
HU (2) HU213731B (es)
IE (1) IE62940B1 (es)
NO (1) NO301588B1 (es)
PT (1) PT99244B (es)
RU (1) RU2067580C1 (es)
SK (5) SK280939B6 (es)
WO (1) WO1992006968A1 (es)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245047A (en) * 1988-02-22 1993-09-14 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
US5149837A (en) * 1988-02-22 1992-09-22 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
US5298627A (en) * 1993-03-03 1994-03-29 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
HRP960312B1 (en) 1995-07-17 2001-10-31 Warner Lambert Co NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS /R-(R*, R*)/-2-(4-FLUOROPHENYL)-"beta", "delta"-DIHYDROXY-5-PHENYL-4-/(PHENYLAMINO)CARBONYL/-1H-PYRROLE -1-HEPTANOIC ACID CALCIUM SALT (2 : 1)
US6087511A (en) * 1996-07-16 2000-07-11 Warner-Lambert Company Process for the production of amorphous [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl )-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid) calcium salt (2:1)
ES2207202T3 (es) * 1998-04-30 2004-05-16 Kaneka Corporation Procedimiento para producir derivados de acido 6-cianometil-1, 3-dioxano-4-acetico.
HU227840B1 (en) * 1999-05-06 2012-05-02 Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag Intermediates of atorvastatin synthesis and process for producing them
IN191236B (es) 1999-05-25 2003-10-11 Ranbaxy Lab Ltd
US20040063969A1 (en) * 1999-10-18 2004-04-01 Egis Gyogyszergyar Rt. Process for the preparation of amorphous atorvastatin calcium
DE60026737T2 (de) 1999-12-17 2006-09-21 Pfizer Science And Technology Ireland Ltd., Dun Laoghaire Verfahren zur herstellung von kristallin atorvastin kalcium
MXPA02004078A (es) 1999-12-17 2002-10-11 Warner Lambert Res & Dev Un proceso a escala industrial para producir sal de hemi calcio de trihidrato de atorvastatin cristalino.
US7300775B2 (en) 1999-12-29 2007-11-27 Verenium Corporation Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents
US7521216B2 (en) 1999-12-29 2009-04-21 Verenium Corporation Nitrilases and methods for making and using them
US20040014195A1 (en) * 1999-12-29 2004-01-22 Diversa Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7608445B1 (en) 1999-12-29 2009-10-27 Verenium Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
JP3844112B2 (ja) 2000-08-23 2006-11-08 高砂香料工業株式会社 ３，５，６−トリヒドロキシヘキサン酸アンモニウム塩誘導体、及びその製造方法
EP1734034A3 (en) 2001-01-09 2007-01-03 Warner-Lambert Company LLC Carboxylic acid salts of beta-alanine esters or -amides
US6476235B2 (en) 2001-01-09 2002-11-05 Warner-Lambert Company Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
WO2002057229A1 (en) * 2001-01-19 2002-07-25 Biocon India Limited FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN)
SI20814A (sl) 2001-01-23 2002-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Priprava amorfnega atorvastatina
SI20848A (sl) 2001-03-14 2002-10-31 Lek, Tovarna Farmacevtskih In Kemijskih Izdelkov, D.D. Farmacevtska formulacija, ki vsebuje atorvastatin kalcij
EE200300597A (et) 2001-06-29 2004-02-16 Warner-Lambert Company Llc [R-(R*,R*)]-2-(4-fluorofenüül)-beeta, delta-dihüdroksü-5-(1-metüületüül)-3-fenüül-4-[fenüülamino)karbonüül]-1H-pürrool-1-hepta anhappe kaltsiumsoola (2:1) (atorvastatiini) kristallilised vormid
GB0116212D0 (en) * 2001-07-03 2001-08-29 Avecia Ltd Process
CZ2004126A3 (cs) 2001-07-30 2004-12-15 Dr. Reddy's Laboratories Limited Krystalické formy VI. A VII. vápenaté soli atorvastatinu
PE20030324A1 (es) * 2001-07-31 2003-04-03 Warner Lambert Co Composiciones farmaceuticas de amlodipina y atorvastatina
CA2456095C (en) * 2001-08-31 2010-05-11 Morepen Laboratories Ltd. An improved process for the preparation of amorphous atorvastatin calcium salt (2:1)
HU227124B1 (en) * 2001-09-14 2010-07-28 Egis Gyogyszergyar Nyilvanosan Polymorphs of 1-pyrrole derivative, intermediate for the preparation of atorvastatin
UA77990C2 (en) * 2001-12-12 2007-02-15 Crystalline calcium salt of (2:1) [r-(r*,r*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrroleheptanic acid
CZ296967B6 (cs) * 2002-02-01 2006-08-16 Zentiva, A.S. Zpusob výroby amorfní formy hemivápenaté soli (3R,5R) 7-[3-fenyl-4-fenylkarbamoyl-2-(4-fluorfenyl)-5-isopropylpyrrol-1-yl]-3,5-dihydroxyheptanové kyseliny (atorvastatinu)
DE10212492B4 (de) * 2002-03-21 2012-02-02 Daimler Ag Kolbenpumpe
WO2003106415A2 (en) * 2002-06-13 2003-12-24 Diversa Corporation Processes for making (r)-ethyl 4-cyano-3-hydroxybutyric acid
CN100357289C (zh) * 2002-08-06 2007-12-26 沃尼尔·朗伯有限责任公司 制备5－(4－氟苯基)－1－[2－((2r,4r)－4－羟基－6－氧代－四氢－吡喃－2－基)乙基]－2－异丙基－4－苯基－1h－吡咯－3－羧酸苯基酰胺的方法
EP1562583A1 (en) * 2002-09-03 2005-08-17 Morepen Laboratories Ltd. Atorvastatin calcium form vi or hydrates thereof
KR100529703B1 (ko) * 2002-09-23 2005-11-17 임광민 키랄 중간체의 제조방법 및 그를 이용한 아토바스타틴의제조방법
HRP20020885B1 (en) * 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
KR100780984B1 (ko) * 2003-04-14 2007-11-29 워너-램버트 캄파니 엘엘씨 5-(4-플루오로페닐)-1-[2-((2ｒ,4ｒ)-4-히드록시-6-옥소-테트라히드로-피란-2-일)에틸]-2-이소프로필-4-페닐-1ｈ-피롤-3-카르복실산 페닐아미드의 제조 방법
CA2523808A1 (en) * 2003-05-16 2004-12-23 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
US20050182125A1 (en) * 2003-05-16 2005-08-18 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
US20040248972A1 (en) * 2003-05-16 2004-12-09 Ambit Biosciences Corporation Compounds and uses thereof
US7790197B2 (en) * 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US7655692B2 (en) * 2003-06-12 2010-02-02 Pfizer Inc. Process for forming amorphous atorvastatin
US20050271717A1 (en) * 2003-06-12 2005-12-08 Alfred Berchielli Pharmaceutical compositions of atorvastatin
EP2522656A3 (en) 2003-07-25 2013-03-20 Redx Pharma Limited Process and Intermediate Compounds Useful in the Preparation of Statins, Particularly Atorvastatin
CN101318923A (zh) * 2003-09-17 2008-12-10 沃尼尔·朗伯有限责任公司 [R－(R*,R*)]－2－(4－氟苯基)－β,δ－二羟基－5－(1－甲基乙基)－3－苯基－4－[(苯基氨基)羰基]－1H－吡咯－1－庚酸的结晶形式
CA2456430A1 (en) * 2004-01-28 2005-07-28 Brantford Chemicals Inc. Improved process for the preparation of amorphous atorvastatin calcium
CA2627940A1 (en) 2004-03-17 2005-10-06 Ranbaxy Laboratories Limited Process for the production of atorvastatin calcium in amorphous form
MXPA06011987A (es) * 2004-04-16 2007-01-16 Pfizer Prod Inc Procedimiento para formar calcio de atorvastatina amorfa.
EP1745020A2 (en) 2004-05-05 2007-01-24 Pfizer Products Incorporated Salt forms of atorvastatin
JP5000502B2 (ja) * 2004-07-16 2012-08-15 レツク・フアーマシユーテイカルズ・デー・デー アトルバスタチンカルシウムの酸化分解生成物
CA2573771C (en) * 2004-07-20 2011-05-10 Warner-Lambert Company Llc Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .gamma.-dihydroxy-5-(1-menthylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1)
JP2008510798A (ja) * 2004-08-27 2008-04-10 バイオコン・リミテッド 非晶質アトルバスタチンカルシウムのための方法
BRPI0519996A2 (pt) 2004-10-28 2009-04-07 Warner Lambert Co processo para formar atorvastatina amorfa
AU2005305460B2 (en) * 2004-11-22 2011-04-21 Dexcel Pharma Technologies Ltd. Stable atorvastatin formulations
EP1819319A1 (en) * 2004-12-02 2007-08-22 Warner-Lambert Company LLC Pharmaceutical compositions of amorphous atorvastatin and process for preparing same
JP2009507822A (ja) * 2005-09-09 2009-02-26 ファイザー・サイエンス・アンド・テクノロジー・アイルランド・リミテッド アトルバスタチン中間体の調製
US20090221839A1 (en) * 2005-09-09 2009-09-03 Pfizer Inc. Preparation of an Atorvastatin Intermediate
US20090216029A1 (en) * 2005-09-16 2009-08-27 Yatendra Kumar Process for the production of atorvastatin calcium in amorphous form
CA2547216A1 (en) 2005-09-21 2007-03-21 Renuka D. Reddy Process for annealing amorphous atorvastatin
DE602006014193D1 (de) 2005-11-21 2010-06-17 Warner Lambert Co Neue formen von är-(r*,r*)ü-2-(4-fluorphenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-ä(phenylamino)carbonylü-1h-pyrrol-1-heptansäure-magnesium
EP1810667A1 (en) 2006-01-20 2007-07-25 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising amorphous atorvastatin
US20100113802A1 (en) * 2006-11-02 2010-05-06 Cadila Pharmaceuticals Limited Process for preparing amorphous atorvastatin hemi calcium salt and its itermediate
US7834195B2 (en) * 2007-01-24 2010-11-16 Apotex Pharmachem Inc. Atorvastatin calcium propylene glycol solvates
EP2115153B1 (en) 2007-03-01 2013-06-05 BP Corporation North America Inc. Nitrilases, nucleic acids encoding them and methods for making and using them
US20110142883A1 (en) * 2007-07-20 2011-06-16 Actavis Group Ptc Ehf Amorphous Coprecipitates of Atorvastatin Pharmaceutically Acceptable Salts
EP2075246A1 (en) 2007-12-27 2009-07-01 M. J. Institute of Research A process for preparation of amorphous form of atorvastatin hemi-calcium salt
US8115015B2 (en) * 2009-01-26 2012-02-14 Cadila Healthcare Limited Process for the preparation of amorphous atorvastatin calcium
HUE025861T2 (en) * 2010-09-09 2016-05-30 Dsm Sinochem Pharm Nl Bv Salts of 7-amino-3,5-dihydroxy-heptanoic acid esters
EP2726456A1 (en) 2011-07-01 2014-05-07 DSM Sinochem Pharmaceuticals Netherlands B.V. Micronized crystals of atorvastatin hemicalcium
WO2016056031A1 (en) 2014-10-08 2016-04-14 Council Of Scientific & Industrial Research Novel diol compounds synthesis and its use for formal synthesis of (2r, 3 s)-3-hydroxypipecolic acid
CN106008251A (zh) * 2016-05-19 2016-10-12 河南豫辰药业股份有限公司 一种2-苯甲撑-3-氧代-4-甲基-n-苯基戊酰胺的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US5003080A (en) * 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives
DE3929913A1 (de) * 1989-09-08 1991-04-04 Hoechst Ag 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte

Also Published As

Publication number Publication date
CZ124697A3 (en) 1997-12-17
CA2092997A1 (en) 1992-04-18
JPH06502162A (ja) 1994-03-10
SK280942B6 (sk) 2000-09-12
PT99244B (pt) 1999-04-30
CZ124797A3 (en) 1997-12-17
CZ282922B6 (cs) 1997-11-12
AU8848091A (en) 1992-05-20
EP0553213A1 (en) 1993-08-04
PT99244A (pt) 1992-09-30
NO301588B1 (no) 1997-11-17
CZ282992B6 (cs) 1997-12-17
RU2067580C1 (ru) 1996-10-10
ES2070519T3 (es) 1995-06-01
HU219237B (en) 2001-03-28
IE913629A1 (en) 1992-04-22
DE69107622D1 (de) 1995-03-30
DE69107622T2 (de) 1995-07-06
CZ209495A3 (en) 1997-12-17
DK0553213T3 (da) 1995-07-17
EP0553213B1 (en) 1995-02-22
NO931421D0 (no) 1993-04-16
HU9301122D0 (en) 1993-08-30
US5103024A (en) 1992-04-07
FI931680A0 (fi) 1993-04-14
SK280938B6 (sk) 2000-09-12
HU9701183D0 (en) 1997-09-29
AU646311B2 (en) 1994-02-17
KR0166385B1 (en) 1999-01-15
IE62940B1 (en) 1995-03-08
FI108539B (fi) 2002-02-15
NO931421L (no) 1993-06-16
KR930702328A (ko) 1993-09-08
WO1992006968A1 (en) 1992-04-30
CZ282994B6 (cs) 1997-12-17
ATE118772T1 (de) 1995-03-15
CZ124597A3 (en) 1997-12-17
HU213731B (en) 1997-09-29
CZ61493A3 (en) 1994-02-16
HUT64049A (en) 1993-11-29
JP3105923B2 (ja) 2000-11-06
SK280940B6 (sk) 2000-09-12
CA2092997C (en) 2002-05-14
FI931680A (fi) 1993-04-14
HK1005026A1 (en) 1998-12-18
SK33993A3 (en) 1993-10-06
CZ282993B6 (cs) 1997-12-17
SK280941B6 (sk) 2000-09-12
CZ283003B6 (cs) 1997-12-17

Similar Documents

Publication Publication Date Title
SK280939B6 (sk) Spôsob syntézy (4r-cis)-1,1-dimetyletyl-6-kyanometyl-2,2- -dimetyl-1,3-dioxán-4-acetátu a medziprodukty tohto spôsobu
US5248793A (en) Process for the synthesis of (4R-cis)-1,1-dimethylethyl 6-iodomethyl or 6-(phenyl-substituted)sulfonyloxymethyl-2,2-dimethyl-1,3-dioxane-4-acetate
US5155251A (en) Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate
RU2269515C2 (ru) Способ синтеза аторвастатина и промежуточный фенилборонат (варианты)
US5385929A (en) [(Hydroxyphenylamino) carbonyl] pyrroles
CZ285554B6 (cs) Způsob výroby trans-6-[2-(substituovaný pyrrol-1-yl)alkyl]-pyran-2-onu
EP0465358B1 (fr) Dérivé thiényl-2 glycidique, son procédé de préparation et son utilisation comme intermédiaire de synthèse
US7812179B2 (en) Process for the preparation of atorvastatin and intermediates
WO2008103016A1 (en) Atorvastatin intermediates and method for producing the same
KR0137884B1 (ko) 콜레스테롤 합성 억제제인 트란스-6-[2-(치환-피롤-1-일)알킬] 피란-2-온의 개량된 제조 방법
KR20050012432A (ko) 아토르바스타틴 합성 중간체의 제조방법
NO177423B (no) Forbedret fremgangsmåte for fremstilling av trans-6-[2-(substituert-pyrrol-yl)alkylÅpyran-2-on-inhibitorer for kolesterolsyntese

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090911